Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Opioid-Related Disorders × Buprenorphine × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Opioid-Related Disorders 1 Lymphoma, Follicular 1

Interventions

Standard of Care 2 X-Rays 1 Ultrasonic Waves 1 Tirzepatide 1 Therapeutics 1 Sublocade 1 Radiography, Abdominal 1 Morphine 1 Methadone 1 Hematologic Tests 1 Educational Status 1 Dosage Forms 1 Buprenorphine, Naloxone Drug Combination 1 Buprenorphine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02611752 2019-11-14

A Multiple Dose Opioid Challenge Study

Braeburn Pharmaceuticals

Phase 2 Completed

47 enrolled 18 charts

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡